Business Context and Reporting Period
Company: BioLife Solutions, Inc. (BLFS)
Filing Type: Form 8-K (Current Report)
Date of Report: January 12, 2026
Reporting Period: Preliminary unaudited results for the fourth quarter and full year ended December 31, 2025.
Key Financial Metrics
The filing announces the issuance of a press release containing preliminary unaudited revenue figures for Q4 and the full year 2025. However, the text of this Form 8-K does not provide specific numerical values for:
- Revenue
- Profit or Net Income
- Cash Flow
- Margins
- Debt or Liquidity positions
Note: Specific financial data is contained in Exhibit 99.1 (Press Release), which is referenced but not included in the provided text.
Material Changes
The filing does not contain specific comparative data or details regarding material changes versus prior periods. It serves solely as a notification that preliminary results have been announced.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on January 12, 2026, regarding its preliminary results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the actual revenue and financial figures for Q4 and FY 2025.
- Verify if the preliminary results include any updates to full-year guidance or forward-looking statements.
- Confirm the impact of these preliminary results on the Company's liquidity and capital resources.
- Check for any subsequent filings that may provide audited or more detailed financial statements.